Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

1. Valproate (Epilim, Depakote) pregnancy prevention programme: updated educational materials

Valproate (Epilim, Depakote) pregnancy prevention programme: updated educational materials Valproate (Epilim▼, Depakote▼) pregnancy prevention programme: updated educational materials - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Valproate (Epilim▼, Depakote (...) ▼) pregnancy prevention programme: updated educational materials In January 2020, healthcare professionals received updated educational materials to support the valproate pregnancy prevention programme. Valproate is contraindicated in girls and women of childbearing potential, unless the conditions of the pregnancy prevention programme are met. Published 12 February 2020 From: Therapeutic area: , , , Contents Advice for healthcare professionals: valproate is contraindicated in girls and women

2020 MHRA Drug Safety Update

2. Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy

Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Ondansetron: small (...) increased risk of oral clefts following use in the first 12 weeks of pregnancy Recent epidemiological studies suggest exposure to ondansetron during the first trimester of pregnancy is associated with a small increased risk of the baby having a cleft lip and/or cleft palate. Published 27 January 2020 From: Therapeutic area: , , Contents Ondansetron: evidence and advice Ondansetron (Zofran), a 5-HT3 receptor antagonist, is authorised for the management of nausea and vomiting induced by cytotoxic

2020 MHRA Drug Safety Update

3. Pregnancy Health: Exercise Programs to Prevent Gestational Hypertension

Pregnancy Health: Exercise Programs to Prevent Gestational Hypertension Pregnancy Health: Gestational Hypertension | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (sufficient evidence) February 2019 Audience Adults Women Setting Clinical/Health Systems Community Strategy Health Education Pregnancy Health (...) : Exercise Programs to Prevent Gestational Hypertension Tabs Snapshot Summary of CPSTF Finding The exercise programs for pregnant women to reduce the development of gestational hypertension. Intervention Programs engage women in regular exercise from before their 16th week of pregnancy through birth. Exercise programs must include one or both of the following: Supervised exercise classes that meet at least three times each week and include 30-60 minutes of moderate-intensity aerobic exercise Regular

2020 Community Preventive Services Task Force

4. Vaccination in pregnancy (VIP)

Vaccination in pregnancy (VIP) Vaccination in pregnancy (VIP) - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance Vaccination in pregnancy (VIP) Advice for GPs on pregnant women who are inadvertently vaccinated against measles, mumps, rubella, chicken pox (...) (varicella) or human papilloma virus. Published 1 May 2010 Last updated 21 January 2020 — From: Contents The Immunisation department at Public Health England ( ( . . Shingles vaccine administration in pregnancy Shingles vaccine (Zostavax®, Generic Name: Varicella Zoster Virus, Marketed by Sanofi Pasteur MSD) is a live viral vaccine that is not recommended for use in pregnancy. Most women of child-bearing age in the UK are known to be immune to chickenpox. You can reassure a pregnant woman immunised

2020 Public Health England

5. Severe vomiting in pregnancy: the priority is to rehydrate

Severe vomiting in pregnancy: the priority is to rehydrate Prescrire IN ENGLISH - Spotlight ''Severe vomiting in pregnancy: the priority is to rehydrate'', 1 February 2020 {1} {1} {1} | | > > > Severe vomiting in pregnancy: the priority is to rehydrate Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Severe vomiting in pregnancy: the priority (...) is to rehydrate In cases of severe nausea and vomiting during pregnancy, priority treatment combines parenteral rehydration and rest. Intense pregnancy-related nausea and vomiting affects about 0.3% to 3% of pregnancies. It exposes the mother to dehydration, electrolyte and metabolic abnormalities and serious complications. The woman loses weight, usually with a loss exceeding 5% of her pre-pregnancy weight. This vomiting is resistant to dietary measures, as well as to doxylamine, a first-choice H1

2020 Prescrire

6. Towards integrated antenatal care for low-risk pregnancy

Towards integrated antenatal care for low-risk pregnancy 2019 www.kce.fgov.be KCE REPORT 326 TOWARDS INTEGRATED ANTENATAL CARE FOR LOW-RISK PREGNANCY 2019 www.kce.fgov.be KCE REPORT 326 HEALTH SERVICES RESEARCH TOWARDS INTEGRATED ANTENATAL CARE FOR LOW-RISK PREGNANCY NADIA BENAHMED, MÉLANIE LEFÈVRE, WENDY CHRISTIAENS, CARL DEVOS, SABINE STORDEUR COLOPHON Title : Towards integrated antenatal care for low-risk pregnancy Authors : Nadia Benahmed (KCE), Mélanie Lefèvre (KCE), Wendy Christiaens (KCE (...) pregnancy. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2020. KCE Reports 326. D/2020/10.273/78. This document is available on the website of the Belgian Health Care Knowledge Centre KCE Report 326 Towards integrated antenatal care for low-risk pregnancy 1 ? TABLE OF CONTENTS 1 INTRODUCTION 12 1.1 ANTENATAL CARE: OBJECTIVES AND COMPONENTS 12 1.2 SCOPE OF THE REPORT 13 2 METHODS 14 2.1 A MULTIMODAL APPROACH 14 2.2 FORMULATION OF RECOMMENDATIONS 14 3 ANTENATAL CARE

2020 Belgian Health Care Knowledge Centre

7. Pregnancy-induced autoimmune hemolytic anemia (AIHA): clinical characteristics, maternal and neonatal outcomes

Pregnancy-induced autoimmune hemolytic anemia (AIHA): clinical characteristics, maternal and neonatal outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

8. Perinatal outcomes in pregnancies with prenatal diagnosis of vasa praevia: systematic review and meta-analysis

Perinatal outcomes in pregnancies with prenatal diagnosis of vasa praevia: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

9. Intimate partner violence during pregnancy associated with maternal anemia: a systematic review

Intimate partner violence during pregnancy associated with maternal anemia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

10. Malaria in pregnancy and adverse birth outcomes: a systematic review and meta-analysis

Malaria in pregnancy and adverse birth outcomes: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

11. Diabetes in Pregnancy

Diabetes in Pregnancy Guideline No. 393-Diabetes in Pregnancy - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 41, Issue 12, Pages 1814–1825.e1 Guideline No. 393-Diabetes in Pregnancy x Howard Berger Correspondence Corresponding author: Dr. Howard Berger , MD x Howard Berger Correspondence Corresponding author: Dr. Howard Berger Toronto, ON x Robert Gagnon , MD Montréal, QC x Mathew Sermer , MD Toronto, ON No. 393 (...) , December 2019 (replaces No. 334, July 2016) DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Figures Appendix A Gestational Diabetes Mellitus Screening and Diagnosis Appendix B Gestational Diabetes Mellitus Postpartum Testing Abstract Objectives This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy. Outcomes The outcomes evaluated were short and long-term maternal outcomes

2020 Society of Obstetricians and Gynaecologists of Canada

12. Maternal Collapse in Pregnancy and the Puerperium Full Text available with Trip Pro

Maternal Collapse in Pregnancy and the Puerperium Maternal Collapse in Pregnancy and the Puerperium - Chu - - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library

2020 Royal College of Obstetricians and Gynaecologists

13. Are healthy weight management interventions effective before, during and after pregnancy?

Are healthy weight management interventions effective before, during and after pregnancy? Knowledge & Library Services (KLS) Evidence Briefing Are healthy weight management interventions effective before, during and after pregnancy? Nicola Pearce-Smith 2nd October 2019 What is the evidence for effective healthy weight management interventions before, during and after pregnancy? KLS Evidence Briefing 2 nd October 2019 Question This briefing summarises the evidence for effective healthy weight (...) management interventions before, during and after pregnancy, including those that reduce gestational weight gain (GWG) or prevent poor maternal and child health outcomes, from January 1 st 2010 to 19 th Sept 2019. Key messages • There were many systematic reviews addressing this topic, but there was no overall consensus on which interventions are the most effective for healthy weight management in pregnant or postpartum women • Some reviews found that dietary interventions alone were significantly more

2020 Public Health England - Evidence Briefings

14. Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes

Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features (...) a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Am J Psychiatry Actions , 177 (1), 76-92 2020 Jan 1 Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliation 1 Departments of Neuroscience

2020 EvidenceUpdates

15. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis

The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis The Safety of Oral Fluconazole During the First Trimester of Pregnancy: A Systematic Review and Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National (...) collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Meta-Analysis BJOG Actions , 126 (13), 1546-1552 Dec 2019 The Safety of Oral Fluconazole During the First Trimester of Pregnancy: A Systematic Review and Meta-Analysis , , , , Affiliations Expand Affiliations 1 Department of Urology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China. 2

2020 EvidenceUpdates

16. Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review Full Text available with Trip Pro

Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library of Medicine National (...) Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Obstet Gynecol Actions , 135 (1), 46-58 Jan 2020 Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review , , Affiliations Expand Affiliation 1 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, the University of Texas Health Science Center at Houston, Houston, Texas; and the Division of Maternal Fetal Medicine, Department of Obstetrics

2020 EvidenceUpdates

17. Antiepileptics and pregnancy: potential long-term effects in children

Antiepileptics and pregnancy: potential long-term effects in children Prescrire IN ENGLISH - Spotlight ''Antiepileptics and pregnancy: potential long-term effects in children'', 1 January 2020 {1} {1} {1} | | > > > Antiepileptics and pregnancy: potential long-term effects in children Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Antiepileptics (...) and pregnancy: potential long-term effects in children FEATURED REVIEW Many women who could become pregnant are exposed to antiepileptic drugs. Yet most of the antiepileptic drugs taken by pregnant women expose the unborn child to the risk of malformations, fetotoxic effects and neonatal disorders. What are the long-term effects of the most widely used antieleptics on children exposed in utero, and how do they compare? Full review (8 pages) available for download by subscribers. Abstract What are the main

2020 Prescrire

18. Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Full Text available with Trip Pro

Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) : Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions , 127 (3), 397-403 Feb 2020 Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial , , , , , , , , Affiliations Expand Affiliations 1 Department of Obstetrics and Gynaecology, Khon Kaen Hospital, Khon Kaen, Thailand. 2

2020 EvidenceUpdates

19. The influence of niacin on pregnancy status and outcomes: a systematic review

The influence of niacin on pregnancy status and outcomes: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2020 PROSPERO

20. The influence of niacin on pregnancy status and outcomes in animal models and pregnancy-related cellular and biochemical responses in vitro: A systematic review

The influence of niacin on pregnancy status and outcomes in animal models and pregnancy-related cellular and biochemical responses in vitro: A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO